What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT05029466 - Psilocybin for Treatment-Resistant Depression
Clinical Trial in Mississauga, Ontario
The purpose of this study is to see if psilocybin, an investigational drug, is safe and well tolerated. Researchers also want to know if psilocybin can improve symptoms of depression. This study will see if psilocybin is safe and well tolerated by tracking changes in suicidal thoughts and behaviour, monitoring if any participants choose to stop participating in the study, and measuring any serious side effects, as... Source record lists lead sponsor Brain and Cognition Discovery Foundation and overall status Completed.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT05029466
- Last Verified
- 2026-06-12
Location
Canadian Rapid Treatment Centre of Excellence (CRTCE), Mississauga, Ontario
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT05029466; status Completed; sponsor Brain and Cognition Discovery Foundation.
Source: https://clinicaltrials.gov/study/NCT05029466
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.